Vanadium Induces VL30 Retrotransposition at an Unusually High Level: A Possible Carcinogenesis Mechanism

Journal of Molecular Biology

Volumn 374, Issue 1, 2007, Pages 80-90

  Noutsopoulos, Dimitrios ^a   Markopoulos, Georgios ^a   Koliou, Maria ^a   Dova, Lefkothea ^b   Vartholomatos, Georgios ^b   Kolettas, Evangelos ^a   Tzavaras, Theodore ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

^b UNIVERSITY HOSPITAL OF IOANNINA   (Greece)

Author keywords

DNA DSBs; hydrogen peroxide; retrotransposition; vanadium; VL30

Indexed keywords

ACETYLCYSTEINE; DEFEROXAMINE; DOUBLE STRANDED DNA; EFAVIRENZ; EPIDERMAL GROWTH FACTOR; HYDROGEN PEROXIDE; PARAQUAT; RNA DIRECTED DNA POLYMERASE; VANADIUM; VANADYL SULFATE;

ANIMAL CELL; ARTICLE; CARCINOGENESIS; CELL LINE; CELL STRAIN 3T3; CONTROLLED STUDY; DNA STRUCTURE; DNA TRANSPOSITION; DOSE RESPONSE; FLUORESCENCE ACTIVATED CELL SORTING; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; INCUBATION TIME; MOUSE; NONHUMAN; OXIDATIVE STRESS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RETROPOSON; ULTRAVIOLET RADIATION; VIRAL LIKE 30 ELEMENT;

EID: 35348992621     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2007.09.012     Document Type: Article

References (55)

1. French N.S., and Norton J.D. Structure and functional properties of mouse VL30 retrotransposons. Biochim. Biophys. Acta 1352 (1997) 33-47
2. Hodgson C.P., Fisk R.Z., Arora P., and Chotani M. Nucleotide sequence of mouse virus-like (VL30) retrotransposon BVL-1. Nucl. Acids Res. 18 (1990) 673
3. Adams S.E., Rathjen P.D., Stanway C.A., Fulton S. M., Malim M.H., Wilson W., et al. Complete nucleotide sequence of a mouse VL30 retro-element. Mol. Cell. Biol. 8 (1988) 2989-2998
4. Scolnick E.M., Vass W.C., Howk R.S., and Duesberg P.H. Defective retrovirus-like 30S RNA species of rat and mouse cells are infectious if packaged by type C helper virus. J. Virol. 29 (1979) 964-972
5. Song X., Wang B., Bromberg M., Hu Z., Konigsberg W., and Garen A. Retroviral-mediated transmission of a mouse VL30 RNA to human melanoma cells promotes metastasis in an immunodeficient mouse model. Proc. Natl. Acad. Sci. USA 99 (2002) 6269-6273
6. Tzavaras T., Eftaxia S., Tavoulari S., Hatzi P., and Angelidis C. Factors influencing the expression of endogenous reverse transcriptases and viral-like 30 elements in mouse NIH3T3 cells. Int. J. Oncol. 23 (2003) 1237-1243
7. Song X., Sui A., and Garen A. Binding of mouse VL30 retrotransposon RNA to PSF protein induces genes repressed by PSF: effects on steroidogenesis and oncogenesis. Proc. Natl. Acad. Sci. USA 101 (2004) 621-626
8. Song X., Sun Y., and Garen A. Roles of PSF protein and VL30 RNA in reversible gene regulation. Proc. Natl. Acad. Sci. USA 102 (2005) 12189-12193
9. Costain W.J., Rasquinha I., Graber T., Luebbert C., Preston E., Slinn J., et al. Cerebral ischemia induces neuronal expression of novel VL30 mouse retrotransposons bound to polyribosomes. Brain Res. 1094 (2006) 24-37
10. Boeke J.D., Garfinkel D.J., Styles C.A., and Fink G.R. Ty elements transpose through an RNA intermediate. Cell 40 (1985) 491-500
11. Ostertag E.M., and Kazazian Jr. H.H. Biology of mammalian L1 retrotransposons. Annu. Rev. Genet. 35 (2001) 501-538
12. Waterston R.H., Lindblad-Toh K., Birney E., Rogers J., Abril J.F., Agarwal P., et al. Initial sequencing and comparative analysis of the mouse genome. Nature 420 (2002) 520-562
13. Srivastava A.K., and Mehdi M.Z. Insulino-mimetic and anti-diabetic effects of vanadium compounds. Diabet. Med. 22 (2005) 2-13
14. Swarup G., Speeg Jr. K.V., Cohen S., and Garbers D.L. Phosphotyrosyl-protein phosphatase of TCRC-2 cells. J. Biol. Chem. 257 (1982) 7298-7301
15. Mukherjee B., Patra B., Mahapatra S., Banerjee P., Tiwari A., and Chatterjee M. Vanadium-an element of atypical biological significance. Toxicol. Letters 150 (2004) 135-143
16. Leopardi P., Villani P., Cordelli E., Siniscalchi E., Veschetti E., and Crebelli R. Assessment of the in vivo genotoxicity of vanadate: analysis of micronuclei and DNA damage induced in mice by oral exposure. Toxicol. Letters 158 (2005) 39-49
17. Bishayee A., Roy S., and Chatterjee M. Characterization of selective induction and alteration of xenobiotic biotransforming enzymes by vanadium during diethylnitrosamine-induced chemical rat liver carcinogenesis. Oncol. Res. 11 (1999) 41-53
18. Basak R., Saha B.K., and Chatterjee M. Inhibition of diethylnitrosamine-induced rat liver chromosomal aberrations and DNA-strand breaks by synergistic supplementation of vanadium and 1alpha,25-dihydroxyvitamin D(3). Biochim. Biophys. Acta 1502 (2000) 273-282
19. Evangelou A.M. Vanadium in cancer treatment. Crit. Rev. Oncol. Hematol. 42 (2002) 249-265
20. Stern A., Yin X., Tsang S.S., Davison A., and Moon J. Vanadium as a modulator of cellular regulatory cascades and oncogene expression. Biochem. Cell. Biol. 71 (1993) 103-112
21. Smith J.B. Vanadium ions stimulate DNA synthesis in Swiss mouse 3T3 and 3T6 cells. Proc. Natl. Acad. Sci. USA 80 (1983) 6162-6166
22. Altamirano-Lozano M., Alvarez-Barrera L., Basurto-Alcantara F., Valverde M., and Rojas E. Reprotoxic and genotoxic studies of vanadium pentoxide in male mice. Teratog. Carcinog. Mutagen. 16 (1996) 7-17
23. Ress N.B., Chou B.J., Renne R.A., Dill J.A., Miller R.A., Roycroft J.H., et al. Carcinogenicity of inhaled vanadium pentoxide in F344/N rats and B6C3F1 mice. Toxicol. Sci. 74 (2003) 287-296
24. Zhang Z., Wang Y., Vikis H.G., Johnson L., Liu G., Li J., et al. Wildtype Kras2 can inhibit lung carcinogenesis in mice. Nature Genet. 29 (2001) 25-33
25. Devereux T.R., Holliday W., Anna C., Ress N., Roycroft J., and Sills R.C. Map kinase activation correlates with K-ras mutation and loss of heterozygosity on chromosome 6 in alveolar bronchiolar carcinomas from B6C3F1 mice exposed to vanadium pentoxide for 2 years. Carcinogenesis 23 (2002) 1737-1743
26. Sakurai H. Vanadium distribution in rats and DNA cleavage by vanadyl complex: implication for vanadium toxicity and biological effects. Environ. Health Perspect. 102 Suppl. 3 (1994) 35-36
27. Shi X., Jiang H., Mao Y., Ye J., and Saffiotti U. Vanadium(IV)-mediated free radical generation and related 2′-deoxyguanosine hydroxylation and DNA damage. Toxicology 106 (1996) 27-38
28. Valko M., Rhodes C.J., Moncol J., Izakovic M., and Mazur M. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem. Biol. Interact. 160 (2006) 1-40
29. Leonard A., and Gerber G.B. Mutagenicity, carcinogenicity and teratogenicity of vanadium compounds. Mutat. Res. 317 (1994) 81-88
30. Gibson D.P., Brauninger R., Shaffi H.S., Kerckaert G.A., LeBoeuf R.A., Isfort R.J., and Aardema M.J. Induction of micronuclei in Syrian hamster embryo cells: comparison to results in the SHE cell transformation assay for National Toxicology Program test chemicals. Mutat. Res. 392 (1997) 61-70
31. NTP toxicology and carcinogenesis studies of vanadium pentoxide (CAS No. 1314-62-1) in F344/N rats and B6C3F1 mice (inhalation). Natl. Toxicol. Program Tech. Rep. Ser. 507 (2002) 1-343
32. Ramirez P., Eastmond D.A., Laclette J.P., and Ostrosky-Wegman P. Disruption of microtubule assembly and spindle formation as a mechanism for the induction of aneuploid cells by sodium arsenite and vanadium pentoxide. Mutat. Res. 386 (1997) 291-298
33. Noutsopoulos D., Vartholomatos G., Kolaitis N., and Tzavaras T. SV40 Large T antigen up-regulates the retrotransposition frequency of viral-like 30 elements. J. Mol. Biol. 361 (2006) 450-461
34. Ostertag E.M., Prak E.T., DeBerardinis R.J., Moran J.V., and Kazazian Jr. H.H. Determination of L1 retrotransposition kinetics in cultured cells. Nucl. Acids Res. 28 (2000) 1418-1423
35. Cortizo A.M., Bruzzone L., Molinuevo S., and Etcheverry S.B. A possible role of oxidative stress in the vanadium-induced cytotoxicity in the MC3T3E1 osteoblast and UMR106 osteosarcoma cell lines. Toxicology 147 (2000) 89-99
36. Tang D., Okada H., Ruland J., Liu L., Stambolic V., Mak T.W., and Ingram A.J. Akt is activated in response to an apoptotic signal. J. Biol. Chem. 276 (2001) 30461-30466
37. Sciamanna I., Landriscina M., Pittoggi C., Quirino M., Mearelli C., Beraldi R., et al. Inhibition of endogenous reverse transcriptase antagonizes human tumor growth. Oncogene 24 (2005) 3923-3931
38. Teng S.C., Kim B., and Gabriel A. Retrotransposon reverse-transcriptase-mediated repair of chromosomal breaks. Nature 383 (1996) 641-644
39. Huang C., Ding M., Li J., Leonard S.S., Rojanasakul Y., Castranova V., et al. Vanadium-induced nuclear factor of activated T cells activation through hydrogen peroxide. J. Biol. Chem. 276 (2001) 22397-22403
40. Heidmann O., and Heidmann T. Retrotransposition of a mouse IAP sequence tagged with an indicator gene. Cell 64 (1991) 159-170
41. Muotri A.R., Chu V.T., Marchetto M.C., Deng W., Moran J.V., and Gage F.H. Somatic mosaicism in neuronal precursor cells mediated by L1 retrotransposition. Nature 435 (2005) 903-910
42. Liu H.S., Jan M.S., Chou C.K., Chen P.H., and Ke N. J. Is green fluorescent protein toxic to the living cells?. Biochem. Biophys. Res. Commun. 260 (1999) 712-717
43. Heidmann T., Heidmann O., and Nicolas J.F. An indicator gene to demonstrate intracellular transposition of defective retroviruses. Proc. Natl. Acad. Sci. USA 85 (1988) 2219-2223
44. Reth M. Hydrogen peroxide as second messenger in lymphocyte activation. Nature Immunol. 3 (2002) 1129-1134
45. Ayaki H., Lee M.J., Sumino K., and Nishio H. Different cytoprotective effect of antioxidants and change in the iron regulatory system in rodent cells exposed to paraquat or formaldehyde. Toxicology 208 (2005) 73-79
46. El-Sawy M., Kale S.P., Dugan C., Nguyen T.Q., Belancio V., Bruch H., et al. Nickel stimulates L1 retrotransposition by a post-transcriptional mechanism. J. Mol. Biol. 354 (2005) 246-257
47. Ameri K., Burke B., Lewis C.E., and Harris A.L. Regulation of a rat VL30 element in human breast cancer cells in hypoxia and anoxia: role of HIF-1. Br. J. Cancer 87 (2002) 1173-1181
48. Massa P.E., Li X., Hanidu A., Siamas J., Pariali M., Pareja J., et al. Gene expression profiling in conjunction with physiological rescues of IKKalpha-null cells with wild type or mutant IKKalpha reveals distinct classes of IKKalpha/NF-kappaB-dependent genes. J. Biol. Chem. 280 (2005) 14057-14069
49. Liu J.P. Studies of the molecular mechanisms in the regulation of telomerase activity. FASEB J. 13 (1999) 2091-2104
50. Chromium, nickel and welding. IARC Monogr. Eval. Carcinog. Risks Hum. 49 (1990) 1-648
51. Meeting of the IARC working group on beryllium, cadmium, mercury and exposures in the glass manufacturing industry. Scand. J. Work Environ. Health 19 (1993) 360-363
52. Herr W. Nucleotide sequence of AKV murine leukemia virus. J. Virol. 49 (1984) 471-478
53. Tzavaras T., Kalogera C., Eftaxia S., Saragosti S., and Pagoulatos G.N. Clone-specific high-frequency retrotransposition of a recombinant virus containing a VL30 promoter in SV40-transformed NIH3T3 cells. Biochim. Biophys. Acta 1442 (1998) 186-198
54. Gasior S.L., Wakeman T.P., Xu B., and Deininger P.L. The human LINE-1 retrotransposon creates DNA double-strand breaks. J. Mol. Biol. 357 (2006) 1383-1393
55. Puschendorf M., Stein P., Oakeley E.J., Schultz R.M., Peters A.H., and Svoboda P. Abundant transcripts from retrotransposons are unstable in fully grown mouse oocytes. Biochem. Biophys. Res. Commun. 347 (2006) 36-43